As doctors and clinicians continue to look for breakthroughs in treatments for COVID-19, could the anti-malarial drug, hydroxycholorquine, prove to be a possible prophylactic? Newt talks with Dr. David Pearce of Sanford Health. Sanford Health is conducting the first controlled hydroxycholoquine clinical trial in the United States.
Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Episode 1051: The End of a Fair Price — Lindsay Owens on How Companies Use Your Data to Charge You More
40:28

Episode 1050: The Midterms, 27 Days Out — McLaughlin and Sosnik on Who Will Control Congress
41:35

Episode 1049: The Exhausted Majority — Who Independents Really Are and Why They'll Decide 2026
35:24